{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:51:50Z","timestamp":1792626710652,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>It has long been known that mutations are at the core of many diseases, most notably cancer. Mutational analysis of tissues and fluids is useful for cancer and other disease diagnosis and management.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Main body<\/jats:title>\n<jats:p>The prevailing cancer development hypothesis posits that cancer originates from mutations in cancer-driving genes that accumulate in tissues over time. These mutations then confer special characteristics to cancer cells, known as the hallmarks of cancer. Mutations in specific driver genes can lead to the formation of cancerous subclones and mutation risk increases with age. New research has revealed an unexpectedly large number of mutations in normal tissues; these findings could have significant implications to the understanding of the pathobiology of cancer and for disease diagnosis and therapy. Here, we discuss how the prevalence of mutations in normal tissues provides novel and relevant insights about clonal development in cancer and other diseases. Specifically, this review will focus on discussing mutations in normal tissues in the context of developing specific, circulating tumor DNA (ctDNA) tests for cancer, and evaluating clonal hematopoiesis as a predictor of blood cancers and cardiovascular pathology, as well as their implications to the phenomena of neural mosaicism in the context of Alzheimer\u2019s disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In view of these new findings, the fundamental differences between the accumulation of genetic alterations in healthy, aging tissues compared to cancer and cardiovascular or neural diseases will need to be better delineated in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12916-020-01763-y","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T02:02:39Z","timestamp":1603936959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Mutations in normal tissues\u2014some diagnostic and clinical implications"],"prefix":"10.1186","volume":"18","author":[{"given":"Clare","family":"Fiala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759\u201367.","journal-title":"Cell"},{"key":"1763_CR2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"1763_CR3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/488467a","volume":"488","author":"A Kondrashov","year":"2012","unstructured":"Kondrashov A. Genetics: the rate of human mutation. Nature. 2012;488:467\u20138.","journal-title":"Nature"},{"key":"1763_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-genet-120417-031501","volume":"52","author":"L Zhang","year":"2018","unstructured":"Zhang L, Vijg J. Somatic mutagenesis in mammals and its implications for human disease and aging. Annu Rev Genet. 2018;52:397\u2013419.","journal-title":"Annu Rev Genet"},{"key":"1763_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-020-1961-1","volume":"578","author":"K Yoshida","year":"2020","unstructured":"Yoshida K, Gowers KHC, Lee-Six H, Chandrasekharan DP, Coorens T, Maughan EF, et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature. 2020;578:266\u201372.","journal-title":"Nature"},{"key":"1763_CR6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-019-1670-9","volume":"574","author":"SF Brunner","year":"2019","unstructured":"Brunner SF, Roberts ND, Wylie LA, Moore L, Aitken SJ, Davies SE, et al. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver. Nature. 2019;574:538\u201342.","journal-title":"Nature"},{"key":"1763_CR7","first-page":"46","volume":"4","author":"D Kwapisz","year":"2017","unstructured":"Kwapisz D. The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? AnnTransl Med. 2017;4:46.","journal-title":"AnnTransl Med"},{"key":"1763_CR8","unstructured":"Natera. FDA grants breakthrough device designation to Natera\u2019s Signatera test. Bloomberg. 2019; \nhttps:\/\/www.natera.com\/press-releases\/fda-grants-b\n\n."},{"key":"1763_CR9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.12688\/f1000research.13440.1","volume":"6","author":"EP Diamandis","year":"2017","unstructured":"Diamandis EP, Fiala C. Can circulating tumor DNA be used for direct and early stage cancer detection? F1000Research. 2017;6:2129.","journal-title":"F1000Research"},{"key":"1763_CR10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12916-018-1157-9","volume":"16","author":"C Fiala","year":"2018","unstructured":"Fiala C, Diamandis EP. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. BMC Med. 2018;16:166.","journal-title":"BMC Med"},{"key":"1763_CR11","doi-asserted-by":"crossref","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","volume":"364","author":"K Yizhak","year":"2019","unstructured":"Yizhak K, Aguet F, Kim J, Hess JM, K\u00fcbler K, Grimsby J, et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science. 2019;364:eaaw0726.","journal-title":"Science"},{"key":"1763_CR12","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Roshan A, Gerstung M, Ellis P, Van Loo P, McLaren S, et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348:880\u20136.","journal-title":"Science"},{"key":"1763_CR13","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.1221068110","volume":"110","author":"C Tomasetti","year":"2013","unstructured":"Tomasetti C, Vogelstein B, Parmigiani G. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci. 2013;110:1999\u20132004.","journal-title":"Proc Natl Acad Sci"},{"key":"1763_CR14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","volume":"574","author":"H Lee-Six","year":"2019","unstructured":"Lee-Six H, Olafsson S, Ellis P, Osborne RJ, Sanders MA, Moore L, et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature. 2019;574:532\u20137 Springer US.","journal-title":"Nature"},{"key":"1763_CR15","unstructured":"Cancer Research UK. Bowel cancer incidence statistics. Cancer Res. UK. 2014; \nhttps:\/\/www.cancerresearchuk.org\/health-profession\n\n."},{"key":"1763_CR16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cgh.2012.09.010","volume":"11","author":"DA Corley","year":"2013","unstructured":"Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172\u201380 Available from: \nhttps:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356512010518\n\n.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1763_CR17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena I, Fowler JC, Wabik A, Lawson ARJ, Cagan A, Stratton MR, et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911\u20137.","journal-title":"Science"},{"key":"1763_CR18","volume":"18","author":"KC Higa","year":"2019","unstructured":"Higa KC, DeGregori J. Decoy fitness peaks, tumor suppression, and aging. Aging Cell. 2019;18:e12938.","journal-title":"Aging Cell"},{"key":"1763_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/d41586-018-07737-8","volume":"565","author":"F Ciccarelli","year":"2019","unstructured":"Ciccarelli F. Mutations differ in normal and cancer cells. Nature. 2019;565:301.","journal-title":"Nature"},{"key":"1763_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"J Kim","year":"2017","unstructured":"Kim J, Bowlby R, Mungall AJ, Robertson AG, Odze RD, Cherniack AD, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541:169\u201375.","journal-title":"Nature"},{"key":"1763_CR21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.aav5697","volume":"362","author":"SJ Chanock","year":"2018","unstructured":"Chanock SJ. The paradox of mutations and cancer. Science. 2018;362:893\u20134.","journal-title":"Science"},{"key":"1763_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41586-018-0811-x","volume":"565","author":"A Yokoyama","year":"2019","unstructured":"Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312\u20137.","journal-title":"Nature"},{"key":"1763_CR23","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1073\/pnas.1601311113","volume":"113","author":"JD Krimmel","year":"2016","unstructured":"Krimmel JD, Schmitt MW, Harrell MI, Agnew KJ, Kennedy SR, Emond MJ, et al. Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues. Proc Natl Acad Sci. 2016;113:6005\u201310.","journal-title":"Proc Natl Acad Sci"},{"key":"1763_CR24","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","volume":"376","author":"MS Anglesio","year":"2017","unstructured":"Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, No\u00eb M, Horlings HM, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376:1835\u201348.","journal-title":"N Engl J Med"},{"key":"1763_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002206","volume":"13","author":"N Nair","year":"2016","unstructured":"Nair N, Camacho-Vanegas O, Rykunov D, Dashkoff M, Camacho SC, Schumacher CA, et al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study. PLoS Med. 2016;13:e1002206.","journal-title":"PLoS Med"},{"key":"1763_CR26","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.18632\/oncotarget.7110","volume":"7","author":"M Schwaederle","year":"2016","unstructured":"Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, et al. Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay. Oncotarget. 2016;7:9707\u201317.","journal-title":"Oncotarget"},{"key":"1763_CR27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.onc.1200812","volume":"14","author":"F Waridel","year":"1997","unstructured":"Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, et al. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene. 1997;14:163\u20139.","journal-title":"Oncogene"},{"key":"1763_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1007108","volume":"14","author":"RA Risques","year":"2018","unstructured":"Risques RA, Kennedy SR. Aging and the rise of somatic cancer-associated mutations in normal tissues. PLoS Genet. 2018;14:1\u201312 Available from: \nhttps:\/\/doi.org\/10.1371\/journal.pgen.1007108\n\n.","journal-title":"PLoS Genet"},{"key":"1763_CR29","doi-asserted-by":"crossref","first-page":"18018","DOI":"10.1073\/pnas.1213736109","volume":"109","author":"M O\u2019Huallachain","year":"2012","unstructured":"O\u2019Huallachain M, Karczewski KJ, Weissman SM, Urban AE, Snyder MP. Extensive genetic variation in somatic human tissues. Proc Natl Acad Sci. 2012;109:18018\u201323.","journal-title":"Proc Natl Acad Sci"},{"key":"1763_CR30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13059-019-1892-z","volume":"20","author":"I Franco","year":"2019","unstructured":"Franco I, Helgadottir HT, Moggio A, Larsson M, Vrta\u010dnik P, Johansson A, et al. Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type. Genome Biol. 2019;20:285.","journal-title":"Genome Biol"},{"key":"1763_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature19768","volume":"538","author":"F Blokzijl","year":"2016","unstructured":"Blokzijl F, De Ligt J, Jager M, Sasselli V, Roerink S, Sasaki N, et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature. 2016;538:260\u20134.","journal-title":"Nature"},{"key":"1763_CR32","volume-title":"Key statistics about liver cancer","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Key statistics about liver cancer. 2019. \nhttps:\/\/www.cancer.org\/cancer\/liver-cancer\/about\/w\n\n."},{"key":"1763_CR33","volume-title":"Key statistics for small intestine cancer","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Key statistics for small intestine cancer. 2019. \nhttps:\/\/www.cancer.org\/cancer\/small-intestine-canc\n\n."},{"key":"1763_CR34","volume-title":"Key statistics for colorectal cancer","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Key statistics for colorectal cancer. 2019. \nhttps:\/\/www.cancer.org\/cancer\/colon-rectal-cancer\/\n\n."},{"key":"1763_CR35","unstructured":"Fiala C, Diamandis EP. Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection. Clin Chem Lab Med. 2020; EPUB. Available from: \nhttps:\/\/www.degruyter.com\/view\/journals\/cclm\/ahead-of-print\/article-10.1515-cclm-2020-0083\/article-10.1515-cclm-2020-0083.xml\n\n."},{"key":"1763_CR36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2017-07-746453","volume":"131","author":"LI Shlush","year":"2018","unstructured":"Shlush LI. Age-related clonal hematopoiesis. Blood. 2018;131:496\u2013504.","journal-title":"Blood"},{"key":"1763_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9\u201316.","journal-title":"Blood"},{"key":"1763_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminhematol.2016.10.002","volume":"54","author":"M Jan","year":"2017","unstructured":"Jan M, Ebert BL, Jaiswal S. Clonal hematopoiesis. Semin Hematol. 2017;54:43\u201350.","journal-title":"Semin Hematol"},{"key":"1763_CR39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson S, Collord G, Ng SWK, Weissbrod O, Mendelson Cohen N, Niemeyer E, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018;559:400\u20134 Springer US.","journal-title":"Nature"},{"key":"1763_CR40","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371:2477\u201387.","journal-title":"N Engl J Med"},{"key":"1763_CR41","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","volume":"99","author":"H Mori","year":"2002","unstructured":"Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci. 2002;99:8242\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1763_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111\u201321.","journal-title":"N Engl J Med"},{"key":"1763_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2019.08.004","volume":"77","author":"TC Luis","year":"2019","unstructured":"Luis TC, Wilkinson AC, Beerman I, Jaiswal S, Shlush LI. Biological implications of clonal hematopoiesis. Exp Hematol. 2019;77:1\u20135.","journal-title":"Exp Hematol"},{"key":"1763_CR44","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355:842\u20137.","journal-title":"Science"},{"key":"1763_CR45","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson CJ, Papula AL, Poon GYP, Wong WH, Young AL, Druley TE, et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science. 2020;367:1449\u201354.","journal-title":"Science"},{"key":"1763_CR46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1126\/science.aba9891","volume":"367","author":"C Curtis","year":"2020","unstructured":"Curtis C. Quantifying mutations in healthy blood. Science. 2020;367:1426\u20137.","journal-title":"Science"},{"key":"1763_CR47","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","volume":"563","author":"MH Lee","year":"2018","unstructured":"Lee MH, Siddoway B, Kaeser GE, Segota I, Rivera R, Romanow WJ, et al. Somatic APP gene recombination in Alzheimer\u2019s disease and normal neurons. Nature. 2018;563:639\u201345.","journal-title":"Nature"},{"key":"1763_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2016.03.009","volume":"4","author":"RS Turner","year":"2016","unstructured":"Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G. An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst). 2016;4:1\u20135.","journal-title":"Alzheimers Dement (Amst)"},{"key":"1763_CR49","volume-title":"HIV Surveillance Report","author":"Centers for Disease Control and Prevention","year":"2016","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report. 2016."},{"key":"1763_CR50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1126\/science.aao4426","volume":"359","author":"MA Lodato","year":"2018","unstructured":"Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, et al. Aging and neurodegeneration are associated with increased mutations in single human neurons. Science. 2018;359:555\u20139.","journal-title":"Science"},{"key":"1763_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mad.2016.03.007","volume":"161","author":"GA Andriani","year":"2017","unstructured":"Andriani GA, Vijg J, Montagna C. Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain. Mech Ageing Dev. 2017;161:19\u201336.","journal-title":"Mech Ageing Dev"},{"key":"1763_CR52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.mad.2011.04.008","volume":"132","author":"F Faggioli","year":"2011","unstructured":"Faggioli F, Vijg J, Montagna C. Chromosomal aneuploidy in the aging brain. Mech Ageing Dev. 2011;132:429\u201336.","journal-title":"Mech Ageing Dev"},{"key":"1763_CR53","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1126\/science.1243472","volume":"342","author":"MJ McConnell","year":"2013","unstructured":"McConnell MJ, Lindberg MR, Brennand KJ, Piper JC, Voet T, Cowing-Zitron C, et al. Mosaic copy number variation in human neurons. Science. 2013;342:632\u20137.","journal-title":"Science"},{"key":"1763_CR54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.semcdb.2013.02.003","volume":"24","author":"DM Bushman","year":"2013","unstructured":"Bushman DM, Chun J. The genomically mosaic brain: aneuploidy and more in neural diversity and disease. Semin Cell Dev Biol. 2013;24:357\u201369.","journal-title":"Semin Cell Dev Biol"},{"key":"1763_CR55","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/cne.21648","volume":"507","author":"JW Westra","year":"2008","unstructured":"Westra JW, Peterson SE, Yung YC, Mutoh T, Barral S, Chun J. Aneuploid mosaicism in the developing and adult cerebellar cortex. J Comp Neurol. 2008;507:1944\u201351.","journal-title":"J Comp Neurol"},{"key":"1763_CR56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-8166-7-20","volume":"7","author":"YB Yurov","year":"2014","unstructured":"Yurov YB, Vorsanova SG, Liehr T, Kolotii AD, Iourov IY. X chromosome aneuploidy in the Alzheimer\u2019s disease brain. Mol Cytogenet. 2014;7:20.","journal-title":"Mol Cytogenet"},{"key":"1763_CR57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/gm183","volume":"2","author":"M Toft","year":"2010","unstructured":"Toft M, Ross OA. Copy number variation in Parkinson\u2019s disease. Genome Med. 2010;2:62 Available from: \nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20828427\n\n.","journal-title":"Genome Med"},{"key":"1763_CR58","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.aax5525","volume":"364","author":"C Tomasetti","year":"2019","unstructured":"Tomasetti C. Mutated clones are the new normal. Science. 2019;364:938\u20139.","journal-title":"Science"},{"key":"1763_CR59","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena I, Raine KM, Gerstung M, Dawson KJ, Haase K, Van Loo P, et al. Universal patterns of selection in cancer and somatic tissues. Cell. 2017;171:1029 1041.e21.","journal-title":"Cell"},{"key":"1763_CR60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/1940-6207.CAPR-16-0024","volume":"9","author":"JD Campbell","year":"2016","unstructured":"Campbell JD, Mazzilli SA, Reid ME, Dhillon SS, Platero S, Beane J, et al. The case for a pre-cancer genome atlas (PCGA). Cancer Prev Res. 2016;9:199\u201324.","journal-title":"Cancer Prev Res"},{"key":"1763_CR61","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","volume":"10","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10:eaat4921.","journal-title":"Sci Transl Med"},{"key":"1763_CR62","doi-asserted-by":"crossref","first-page":"eaav3873","DOI":"10.1126\/scitranslmed.aav3873","volume":"10","author":"E Heitzer","year":"2018","unstructured":"Heitzer E, Speicher MR. One size does not fit all: Size-based plasma DNA diagnostics. Sci Transl Med. 2018;10:eaav3873.","journal-title":"Sci Transl Med"},{"key":"1763_CR63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","volume":"570","author":"S Cristiano","year":"2019","unstructured":"Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570:385\u20139.","journal-title":"Nature"},{"key":"1763_CR64","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, Cummings SR, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31:745\u201359.","journal-title":"Ann Oncol"},{"key":"1763_CR65","doi-asserted-by":"crossref","first-page":"eabb9601","DOI":"10.1126\/science.abb9601","volume":"369","author":"AM Lennon","year":"2020","unstructured":"Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020;369:eabb9601.","journal-title":"Science"},{"key":"1763_CR66","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13059-019-1919-5","volume":"20","author":"PE Garc\u00eda-Nieto","year":"2019","unstructured":"Garc\u00eda-Nieto PE, Morrison AJ, Fraser HB. The somatic mutation landscape of the human body. Genome Biol. 2019;20:298.","journal-title":"Genome Biol"},{"key":"1763_CR67","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"1763_CR68","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41586-020-2329-2","volume":"581","author":"BB Cummings","year":"2020","unstructured":"Cummings BB, Karczewski KJ, Kosmicki JA, Seaby EG, Watts NA, Singer-Berk M, et al. Transcript expression-aware annotation improves rare variant interpretation. Nature. 2020;581:452\u20138.","journal-title":"Nature"},{"key":"1763_CR69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2267-z","volume":"581","author":"EV Minikel","year":"2020","unstructured":"Minikel EV, Karczewski KJ, Martin HC, Cummings BB, Whiffin N, Rhodes D, et al. Evaluating drug targets through human loss-of-function genetic variation. Nature. 2020;581:459\u201364.","journal-title":"Nature"},{"key":"1763_CR70","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins RL, Brand H, Karczewski KJ, Zhao X, Alf\u00f6ldi J, Francioli LC, et al. A structural variation reference for medical and population genetics. Nature. 2020;581:444\u201351.","journal-title":"Nature"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01763-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01763-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T02:03:23Z","timestamp":1603937003000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01763-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01763-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"12 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EPD declares that he holds an advisory\/consultant role with Abbott Diagnostics. CF has nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}